Abstract:Background: Restless legs syndrome (RLS) might worsen sleep quality and quality of life in people with Parkinson’s disease (PwPD). Objective: The main aim of the present study is to explore the associations between RLS and sleep, quality of life and other non-motor symptoms (NMS) in a sample of PwPD. Methods: We compared the clinical features of 131 PwPD with and without RLS, in a cross-sectional study. We used several validated scales for assessment: the International Restless Legs Syndrome Study Group rating… Show more
“…Various comorbidities such as kidney disease, cardiovascular diseases, obstructive lung disease, diabetes mellitus, hypothyroidism, chronic liver disease, and neurological, rheumatological and respiratory disorders may accompany RLS [ 2 , 16 , 17 , 18 , 19 , 40 ]. In a cross-sectional study including 5324 subjects, high cholesterol and hypertension were associated with RLS [ 41 ].…”
Section: Discussionmentioning
confidence: 99%
“…Patients with RLS could be deficient in vitamins D and B12 [ 14 , 15 ]. Various comorbidities such as kidney disease, cardiovascular diseases, diabetes mellitus, hypothyroidism, chronic liver disease, and neurological, rheumatological and respiratory disorders accompany RLS [ 2 , 16 , 17 , 18 , 19 ]. In our recent study, a significantly higher number of amalgam dental fillings were found in older adults with RLS as compared to the subjects without RLS symptoms [ 20 ].…”
Background: We examined the association between restless legs syndrome (RLS) and comprehensive geriatric assessment (CGA) data in two older European populations. The second goal was to evaluate correlates of their quality of life (QoL). Methods: Diagnostic criteria of the International RLS Study Group (IRLSSG) and elements of CGA were used in this study. Results: Among the examined 246 participants, 77 (31.3%) suffered from RLS, more often in the UK (39.4%) than in Poland (25.4%) (p = 0.019). In the multivariate logistic regression model, female sex [OR (CI) = 3.29 (1.51–7.21); p = 0.0014], the number of medications per day [OR (CI) = 1.11 (1.02–1.20); p = 0.011] and alcohol consumption [OR (CI) = 5.41 (2.67–10.95); p < 0.001] increased the probability of RLS. Residing in Poland [OR (CI) = 3.06 (1.36–6.88); p = 0.005], the presence of RLS [OR (CI) = 2.90 (1.36–6.17); p = 0.004], chronic heart failure, [OR (CI) = 3.60 (1.75–7.41); p < 0.001], osteoarthritis [OR (CI) = 2.85 (1.47–5.49); p = 0.0016], and urinary incontinence [OR (CI) = 4.74 (1.87–11.9); p < 0.001] were associated with a higher probability of mobility dimension problems in the QoL. Higher physical activity was related to a lower probability of mobility problems [OR (CI) = 0.85 (0.78–0.92); p < 0.001]. Conclusions: female sex, the number of medications and alcohol consumption are independent correlates of RLS in older adults. RLS together with several chronic medical conditions and a low physical activity level were independent correlates of the mobility dimension of the QoL.
“…Various comorbidities such as kidney disease, cardiovascular diseases, obstructive lung disease, diabetes mellitus, hypothyroidism, chronic liver disease, and neurological, rheumatological and respiratory disorders may accompany RLS [ 2 , 16 , 17 , 18 , 19 , 40 ]. In a cross-sectional study including 5324 subjects, high cholesterol and hypertension were associated with RLS [ 41 ].…”
Section: Discussionmentioning
confidence: 99%
“…Patients with RLS could be deficient in vitamins D and B12 [ 14 , 15 ]. Various comorbidities such as kidney disease, cardiovascular diseases, diabetes mellitus, hypothyroidism, chronic liver disease, and neurological, rheumatological and respiratory disorders accompany RLS [ 2 , 16 , 17 , 18 , 19 ]. In our recent study, a significantly higher number of amalgam dental fillings were found in older adults with RLS as compared to the subjects without RLS symptoms [ 20 ].…”
Background: We examined the association between restless legs syndrome (RLS) and comprehensive geriatric assessment (CGA) data in two older European populations. The second goal was to evaluate correlates of their quality of life (QoL). Methods: Diagnostic criteria of the International RLS Study Group (IRLSSG) and elements of CGA were used in this study. Results: Among the examined 246 participants, 77 (31.3%) suffered from RLS, more often in the UK (39.4%) than in Poland (25.4%) (p = 0.019). In the multivariate logistic regression model, female sex [OR (CI) = 3.29 (1.51–7.21); p = 0.0014], the number of medications per day [OR (CI) = 1.11 (1.02–1.20); p = 0.011] and alcohol consumption [OR (CI) = 5.41 (2.67–10.95); p < 0.001] increased the probability of RLS. Residing in Poland [OR (CI) = 3.06 (1.36–6.88); p = 0.005], the presence of RLS [OR (CI) = 2.90 (1.36–6.17); p = 0.004], chronic heart failure, [OR (CI) = 3.60 (1.75–7.41); p < 0.001], osteoarthritis [OR (CI) = 2.85 (1.47–5.49); p = 0.0016], and urinary incontinence [OR (CI) = 4.74 (1.87–11.9); p < 0.001] were associated with a higher probability of mobility dimension problems in the QoL. Higher physical activity was related to a lower probability of mobility problems [OR (CI) = 0.85 (0.78–0.92); p < 0.001]. Conclusions: female sex, the number of medications and alcohol consumption are independent correlates of RLS in older adults. RLS together with several chronic medical conditions and a low physical activity level were independent correlates of the mobility dimension of the QoL.
“…Certain conditions, such as iron deficiency, anemia, pregnancy, end-stage renal disease, diabetes mellitus, and peripheral neuropathy, can exacerbate or contribute to RLS. Many neurodegenerative diseases, including Parkinson's disease, spinocerebellar ataxias, Huntington's disease, and hereditary spastic paraparesis, have been associated with a higher occurrence of RLS [209][210][211][212]. So far, only four studies assessed this non-motor symptom in ALS patients [213][214][215][216].…”
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive degeneration of both upper and lower motor neurons. A defining histopathological feature in approximately 97% of all ALS cases is the accumulation of phosphorylated trans-activation response (TAR) DNA-binding protein 43 protein (pTDP-43) aggregates in the cytoplasm of neurons and glial cells within the central nervous system. Traditionally, it was believed that the accumulation of TDP-43 aggregates and subsequent neurodegeneration primarily occurs in motor neurons. However, contemporary evidence suggests that as the disease progresses, other systems and brain regions are also affected. Despite this, there has been a limited number of clinical studies assessing the non-motor symptoms in ALS patients. These studies often employ various outcome measures, resulting in a wide range of reported frequencies of non-motor symptoms in ALS patients. The importance of assessing the non-motor symptoms reflects in a fact that they have a significant impact on patients’ quality of life, yet they frequently go underdiagnosed and unreported during clinical evaluations. This review aims to provide an up-to-date overview of the current knowledge concerning non-motor symptoms in ALS. Furthermore, we address their diagnosis and treatment in everyday clinical practice.
“…There may also be accompanying movements as a result of patients trying to relieve their discomfort which is important information that may aid clinical diagnosis. The reported prevalence of RLS is around 50 % in PD population studies [115] , [116] , [117] , [118] . The diagnosis of RLS in PD, as in the general population, is based primarily on clinical interview and evaluation but this can be supplemented with the sensory component of the suggested immobilisation test (SIT) test showing an increase in sensory leg discomfort [109] , [119] .…”
Section: Periodic Limb Movement During Sleep and Restless Leg Syndromementioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.